MiLaboratories and Miltenyi Biotec have formed a groundbreaking partnership that will revolutionize the field of next-generation therapies. MiLaboratories, a prominent player in RNA immune technologies, will provide Miltenyi Biotec with exclusive rights to its state-of-the-art RNA kit technology for immune sequencing. This collaboration will combine MiLaboratories' cutting-edge technology with Miltenyi Biotec's expertise in production and commercialization, resulting in significant advancements in the field.
The integration of MiLaboratories' renowned software solutions, MiXCR and Platforma, into Miltenyi Biotec's offerings is another key aspect of this partnership. These software platforms are leaders in next-generation sequencing data analysis, providing researchers with powerful and user-friendly tools for genomic data interpretation. By purchasing RNA kits from Miltenyi Biotec, customers will now have seamless access to MiXCR and Platforma, greatly enhancing their research capabilities and efficiency.
No comments yet